Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which include its ability to deliver precise and accurate results and lesser time consumption at about same prices. The flow cytometry technology is widely used in the various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV and hematological malignancies. Rising count of patients suffering from HIV and cancer and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need of flow cytometry in the effective diagnosis and monitoring of diseases.
World flow cytometry market is set to grow at a remarkable pace in the coming years, attributed to technological advancements and high adoption in various research and diagnostic applications. In addition, the advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics and marine biology would further supplement the market growth. Further, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. On the other hand, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users and the limited availability of technical expertise are likely to impede the market growth. The preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.
The world flow cytometry market is estimated to reach $7.0 billion by 2022, registering a CAGR of 16.0% over the forecast period. The report segments the world flow cytometry market based on components, technologies, applications, end users and geography. Based on components, the market is segmented into instruments, reagents, software and services. Instruments accounted for the highest revenue-generating segment in 2014, owing to the technological advancements, demand for highly efficient replaceable components and widening scope of flow cytometry applications in newer diseases. Based on technology, the market is segmented into bead based and cell based technologies. Cell based flow cytometry would constitute the highest revenue generating segment throughout the forecast period due to its widespread use across all the applications. Based on application, world flow cytometry market is segmented into academic and clinical research, and diagnostic applications. Academic and clinical research application was the major revenue generating segment in 2014, however, diagnostics segment is projected as the fastest growing segment. The world flow cytometry end users market is segmented into commercial organizations, medical schools and research labs, hospitals, academics and others. Commercial organizations was the highest revenue generating end-user segment in 2014, due to high adoption of flow cytometry in drug discovery process and clinical research.
Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA. North America was the leading region in 2014, supplemented by rapid technological advancements, high R&D investment and widespread use of flow cytometry in research and diagnostic activities. Asia Pacific region would emerge as the most lucrative market over the forecast period owing to outsourcing of R&D activities in this region and increasing incidences of diseases such as cancer and HIV.
The report provides a comprehensive analysis of the leading companies operating in the world flow cytometry market. Key companies profiled in the report are Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company , EMD Millipore, Sysmex Corporation, Affymetix Inc., Luminex Corporation, Thermo Fischer Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec, Inc. and Agilent Technologies, Inc.
KEY MARKET BENEFITS:
KEY MARKET SEGMENTS:
The world flow cytometry market is segmented as:
Table of Contents
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Research methodology
1.3.1 Secondary research
1.4 Primary research
1.4.1 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Low bargaining power of suppliers
3.3.2 High bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 High competitive rivalry
3.3.5 Low threat of substitutes
3.4 Market share analysis, 2014
3.5 Reimbursement scenario
3.6 Regulatory issues
3.6.1 Challenges in FDA clearance
3.6.2 Impact of ASR rule
3.6.3 Validation challenges: cellbased
3.6.4 Validation requirements (CLIA, CAP)
3.6.5 LDT guidelines on cellbased fluorescence
3.6.6 Change in regulations
3.7 Drivers
3.7.1 Technological advancements
3.7.2 Large scale adoption of flow cytometry technique in research and diagnosis applications
3.7.3 Increasing applications across novel fields
3.7.4 Augmented R&D investment
3.7.5 Rising incidences of HIV and cancer
3.8 Restraints
3.8.1 High cost of instrument
3.8.2 Lack of awareness among consumers
3.8.3 Limited technical expertise
3.9 Opportunities
3.9.1 Lucrative opportunities in diagnostics
3.9.2 Emerging role of flow cytometry in drug discovery and development
CHAPTER 4 WORLD FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Instruments
4.2.1 Key market trends
4.2.2 Competitive landscape
4.2.3 Key growth factors and opportunities
4.2.4 Market size and forecast
4.2.5 Platforms
4.2.5.1 Market size and forecast
4.2.5.2 Sorters
4.2.5.2.1 MARKET SIZE AND FORECAST
4.2.5.3 Analysers
4.2.5.3.1 MARKET SIZE AND FORECAST
4.2.6 Replaceable components
4.2.6.1 Market size and forecast
4.2.6.2 Filters
4.2.6.2.1 MARKET SIZE AND FORECAST
4.2.6.3 Lasers
4.2.6.3.1 MARKET SIZE AND FORECAST
4.2.6.4 Detectors
4.2.6.4.1 MARKET SIZE AND FORECAST
4.2.6.5 Others
4.2.6.5.1 MARKET SIZE AND FORECAST
4.2.7 Accessories
4.2.7.1 Market size and forecast
4.3 Reagents and consumables
4.3.1 Competitive landscape
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Antibodies
4.3.4.1 Market size and forecast
4.3.5 Dyes
4.3.5.1 Market size and forecast
4.3.6 Beads
4.3.6.1 Market size and forecast
4.3.7 Others
4.3.7.1 MArket size and forecast
4.4 Software
4.4.1 Key market trends
4.4.2 Competitive landscape
4.4.3 Key growth factors and opportunities
4.4.4 Market size and forecast
4.5 Services
4.5.1 Key market trends
4.5.2 Competitive landscape
4.5.3 Key growth factors and opportunities
4.5.4 Market size and forecast
CHAPTER 5 WORLD FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2014-2022
5.1 Overview
5.1.1 Market size and forecast
5.2 Bead-based flow cytometry
5.2.1 Key market trends
5.2.2 Competitive landscape
5.2.3 Key growth factors and opportunities
5.2.4 Market size and forecast
5.3 Cell based flow cytometers
5.3.1 Key market trends
5.3.2 Competitive landscape
5.3.3 Key growth factors and opportunities
5.3.4 Market size and forecast
CHAPTER 6 WORLD FLOW CYTOMETRY MARKET, BY APPLICATION, 2014-2022
6.1 Overview
6.1.1 Market size and forecast
6.2 Academic and clinical applications
6.2.1 Key market trends
6.2.2 Competitive landscape
6.2.3 Key growth factors and opportunities
6.2.4 Market size and forecast
6.2.5 Cell cycle analysis and cell proliferation
6.2.5.1 Market size and forecast
6.2.6 Apoptosis
6.2.6.1 Market size and forecast
6.2.7 Sorting/Screening
6.2.7.1 Market size and forecast
6.2.8 Transfection and cell viability
6.2.8.1 Market size and forecast
6.2.9 Others
6.2.9.1 Market size and forecast
6.3 Diagnostic applications
6.3.1 Key market trends
6.3.2 Competitive landscape
6.3.3 Key growth factors and opportunities
6.3.4 Market size and forecast
6.3.5 Organ transplantation
6.3.5.1 Market size and forecast
6.3.6 Hematological malignancies
6.3.6.1 Market size and forecast
6.3.7 Cancer and solid tumor
6.3.7.1 Market size and forecast
6.3.8 HIV
6.3.8.1 Market size and forecast
6.3.9 Others
6.3.9.1 Market size and forecast
CHAPTER 7 WORLD FLOW CYTOMETRY MARKET, BY END USER, 2014-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 Commercial organizations
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Medical schools and clinical testing labs
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Hospitals
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.5 Academic institutions
7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.6 Others
7.6.1 Market size and forecast
CHAPTER 8 WORLD FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Competitive landscape
8.2.3 Key growth factors and opportunities
8.2.4 Market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Competitive landscape
8.3.3 Key growth factors and opportunities
8.3.4 Market size and forecast
8.4 Asia Pacific
8.4.1 Key market trends
8.4.2 Competitive landscape
8.4.3 Key growth factors and opportunities
8.4.4 Market size and forecast
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Competitive landscape
8.5.3 Key growth factors and opportunities
8.5.4 Market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1 Danaher Corporation (Beckman Coulter)
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Business performance
9.1.5 Key strategic moves and developments
9.1.6 SWOT analysis
9.2 Affymetrix, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Business performance
9.2.5 Key strategic moves and developments
9.2.6 SWOT analysis
9.3 Sysmex Corporation
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Business performance
9.3.5 Key strategic moves and developments
9.3.6 SWOT Analysis
9.4 Becton, Dickinson and Co.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Key strategic moves and developments
9.4.6 SWOT analysis
9.5 Merck Millipore
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Key strategic moves and developments
9.5.5 SWOT analysis
9.6 Luminex Corporation
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Business performance
9.6.5 Key strategic moves and developments
9.6.6 SWOT Analysis
9.7 Thermo Fisher Scientific
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segment
9.7.4 Business performance
9.7.5 Key strategic moves and developments
9.7.6 SWOT analysis
9.8 Bio-Rad Laboratories, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Business performance
9.8.5 Key strategic moves and developments
9.8.6 SWOT analysis
9.9 Miltenyi Biotec, GmbH.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Business performance
9.9.5 Key strategic moves and developments
9.9.6 SWOT analysis.
9.10 Dako (Agilent Technologies)
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Business performance
9.10.5 Key strategic moves and developments
9.10.6 SWOT analysis
List of Figures
FIG. 1 FLOW CYTOMETRY MARKET DEFINITION
FIG. 2 TOP FACTORS IMPACTING WORLD FLOW CYTOMETRY MARKET (2014-2022)
FIG. 3 TOP INVESTMENT POCKETS IN WORLD FLOW CYTOMETRY MARKET
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
FIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 6 PORTERS FIVE FORCE ANALYSIS
FIG. 7 MARKET SHARE ANALYSIS, 2014
FIG. 8 TYPES OF PLATFORM
FIG. 9 NUMBER OF TRANSPLANTS PERFORMED IN THE UNITED STATES (2013)
FIG. 10 ESTIMATED NEW CASES OF LEUKEMIA, LYMPHOMA AND MYELOMA (2014)
FIG. 11 ESTIMATED NEW CASES OF LEUKEMIA, BY TYPE, (2013)
FIG. 12 ESTIMATED NEW CASES AND DEATHS IN USA (2014)
FIG. 13 TOP TEN COUNTRIES WITH CANCER POPULATION (PER 100,000 PEOPLE) 2013
FIG. 14 PREVALENCE OF HIV/AIDS (TOP TEN COUNTRIES), 2013
FIG. 15 ESTIMATED NUMBER OF NEW CANCER CASES AND DEATHS, BY SITES USA (2014)
FIG. 16 DANAHER CORPORTAION, % REVENUE, BY BUSINESS SEGMENTS, (2014)
FIG. 17 DANAHER CORPORATION, % REVENUE, BY GEOGRAPHY (2014)
FIG. 18 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 19 EBIOSCIENCE SEGMENTS, REVENUE 2012-2014 ($MILLION)
FIG. 20 AFFYMETRIX INC.%REVENUE, BY GEOGRAPHY (2014)
FIG. 21 SWOT ANALYSIS OF AFFYMETRIX, INC.
FIG. 22 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014
FIG. 23 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014
FIG. 24 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)
FIG. 25 SWOT ANALYSIS OF SYSMEX CORPORATION
FIG. 26 BECTON, DICKINSON AND COMPANY, % REVENUE BY BUSINESS SEGMENT (2014)
FIG. 27 BECTON, DICKINSON AND COMPANY, % REVENUE, BY GEOGRAPHY (2014)
FIG. 28 SWOT ANALYSIS OF BECTON, DICKINSON AND COMPANY
FIG. 29 MERCK MILLIPORE, % REVENUE, BY BUSINESS SEGMENT (2014)
FIG. 30 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 31 LUMINEX CORPORATION,% REVENUE, BY GEOGRAPHY (2014)
FIG. 32 SWOT ANALYSIS OF LUMINEX CORPORATION
FIG. 33 THERMO FISHER SCIENTIFIC, INC.%REVENUE, BY BUSINESS UNITS, 2014 ($MILLION)
FIG. 34 THERMO FISHER SCIENTIFIC INC. REVENUE, 2012- 2014, ($MILLION)
FIG. 35 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIG. 36 BIO-RAD LABORATORIES INC. REVENUE, 20122014, $MILLION
FIG. 37 BIO-RAD LABORATORIES% REVENUE, BY BUSINESS UNITS (2014)
FIG. 38 BIO-RAD LABORATORIES% REVENUE, BY GEOGRAPHY (2014)
FIG. 39 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
FIG. 40 SWOT ANALYSIS OF MILTENYI BIOTEC GMBH
FIG. 41 AGILENT TECHNOLOGIES INC., %REVENUE BY BUSINESS UNITS, 2014 ($MILLION)
FIG. 42 AGILENT TECHNOLOGIES, INC.% REVENUE BY GEOGRAPHY (2014)
FIG. 43 SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC.
List of Tables
TABLE 1 WORLD FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022 ($MILLION)
TABLE 2 WORLD FLOW CYTOMETRY MARKET, BY INSTRUMENTS, 2014-2022 ($MILLION)
TABLE 3 WORLD FLOW CYTOMETRY INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4 WORLD FLOW CYTOMETRY INSTRUMENT MARKET, BY PLATFORMS, 2014-2022 ($MILLIONS)
TABLE 5 WORLD FLOW CYTOMETRY PLATFORM MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6 TYPES OF PLATFORM
TABLE 7 TYPES OF SORTERS
TABLE 8 WORLD FLOW CYTOMETRY SORTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9 WORLD FLOW CYTOMETRY ANALYZERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10 ANALYZERS BY KEY PLAYERS
TABLE 11 WORLD FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY TYPES, 2014-2022 ($MILLION)
TABLE 12 WORLD FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 TYPES OF FILTERS
TABLE 14 WORLD FLOW CYTOMETRY FILTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15 WORLD FLOW CYTOMETRY LASERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 TYPES OF DETECTORS
TABLE 17 WORLD FLOW CYTOMETRY DETECTORS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18 WORLD FLOW CYTOMETRY OTHER COMPONENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19 WORLD FLOW CYTOMETRY ACCESSORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 WORLD FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 21 WORLD FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22 WORLD FLOW CYTOMETRY ANTIBODIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23 WORLD FLOW CYTOMETRY DYES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 24 WORLD FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 WORLD FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26 WORLD FLOW CYTOMETRY SOFTWARE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 27 WORLD FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 28 WORLD FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 29 WORLD BEAD BASED FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 30 WORLD CELL BASED FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 31 WORLD FLOW CYTOMETRY MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 32 WORLD FLOW CYTOMETRY APPLICATION MARKET, BY ACADEMIC AND CLINICAL RESEARCH APPLICATION, 2014-2022 ($MILLION)
TABLE 33 WORLD FLOW CYTOMETRY ACADEMIC AND CLINICAL RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 34 WORLD FLOW CYTOMETRY CELL CYCLE ANALYSIS AND CELL PROLIFERATION APPLICATIONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 35 WORLD FLOW CYTOMETRY APOPTOSIS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 36 WORLD FLOW CYTOMETRY SORTING/SCREENING, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 37 WORLD FLOW CYTOMETRY TRANSFECTION AND CELL VIABILITY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 38 WORLD FLOW CYTOMETRY OTHER RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 39 WORLD FLOW CYTOMETRY MARKET, BY DIAGNOSTIC APPLICATION, 2014-2022 ($MILLION)
TABLE 40 WORLD FLOW CYTOMETRY DIAGNOSTIC APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 41 WORLD FLOW CYTOMETRY ORGAN TRANSPLANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 42 WORLD FLOW CYTOMETRY HEMATOLOGICAL MALIGNANCIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 43 WORLD FLOW CYTOMETRY CANCER AND SOLID TUMOR MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 44 WORLD FLOW CYTOMETRY HIV INFECTION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 45 WORLD FLOW CYTOMETRY OTHER DIAGNOSTIC APPLICATION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 46 WORLD FLOW CYTOMETRY MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 47 WORLD FLOW CYTOMETRY COMMERCIAL ORGANIZATIONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 48 WORLD FLOW CYTOMETRY MEDICAL SCHOOLS AND CLINICAL TESTING LABS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 49 WORLD FLOW CYTOMETRY HOSPITALS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 50 WORLD FLOW CYTOMETRY ACADEMIC INSTITUTION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 51 WORLD FLOW CYTOMETRY OTHER END USER MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 52 WORLD FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 53 NORTH AMERICA FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022 ($MILLION)
TABLE 54 EUROPE FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)
TABLE 55 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)
TABLE 56 LAMEA FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)
TABLE 57 COMPANY SNAPSHOT OF DANAHER CORPORATION
TABLE 58 DANAHER CORPORATION OPERATING SEGMENTS
TABLE 59 COMPANY SPANSHOT OF AFFYMETRIX, INC.
TABLE 60 AFFYMETIX INC., OPERATING SEGMENTS
TABLE 61 SNAPSHOT OF SYSMEX CORPORATION
TABLE 62 SYSMEX CORPORATION, OPERATING SEGMENTS
TABLE 63 COMPANY SNAPSHOT OF BECTON, DICKINSON AND COMPANY
TABLE 64 BECTON , DICKINSON AND COMPANY OPERATING SEGMENTS
TABLE 65 SNAPSHOT OF MERCK MILLIPORE
TABLE 66 COMPANY SNAPSHOT OF LUMINEX CORPORATION
TABLE 67 LUMINEX CORPORATION OPERATING SEGMENTS
TABLE 68 COMPANY SNAPSHOT THERMO FISHER SCIENTIFIC INC
TABLE 69 THERMO FISHER SCIENTIFIC INC. OPERATING SEGMENTS
TABLE 70 COMPANY SNAPSHOT OF BIO-RAD LABORATORIES, INC.
TABLE 71 BIO-RAD LABORATORIES, INC. OPERATING SEGMENTS
TABLE 72 COMPANY SNAPSHOT OF MILTENYI BIOTEC GMBH.
TABLE 73 MILTENYI BIOTEC, GMBH. OPERATING SEGMENTS
TABLE 74 COMPANY SNAPSHOT OF AGILENT TECHNOLOGIES, INC.
TABLE 75 AGILENT TECHNOLOGIES, INC., OPERATING SEGMENTS
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
$ 3950
Published On : April 2019
$ 3000
